Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1972 Feb;51(2):307–313. doi: 10.1172/JCI106815

Coagulant Activity of Leukocytes. TISSUE FACTOR ACTIVITY

J Niemetz 1,2
PMCID: PMC302128  PMID: 4333021

Abstract

Peritoneal leukocytes harvested from rabbits which have received two spaced doses of endotoxin have significantly greater (10-fold) coagulant activity than leukocytes from control rabbits. The coagulant activity accelerates the clotting of normal plasma and activates factor X in the presence of factor VII and calcium and is therefore regarded as tissue factor. A total of 40-80 mg tissue factor activity was obtained from the peritoneal cavity of single endotoxin-treated rabbits. In leukocyte subcellular fractions, separated by centrifugation, the specific tissue factor activity sedimented mainly at 14,500 g and above. The procoagulant activity was destroyed after heating for 10 min at 65°C but was preserved at lower temperatures. Polymyxin B, when given with the first dose of endotoxin, reduced both the number of peritoneal leukocytes and their tissue factor activity by two-thirds. When given immediately before the second dose of endotoxin, polymyxin B had no inhibitory effect.

Full text

PDF
307

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BACHMANN F., DUCKERT F., KOLLER F. The Stuart-Prower factor assay and its clinical significance. Thromb Diath Haemorrh. 1958 May 1;2(1-2):24–38. [PubMed] [Google Scholar]
  2. BAKER W. G., BANG N. U., NACHMAN R. L., RAAFAT F., HOROWITZ H. I. HYPOFIBRINOGENEMIC HEMORRHAGE IN ACUTE MYELOGENOUS LEUKEMIA TREATED WITH HEPARIN. WITH AUTOPSY FINDINGS OF WIDESPREAD INTRAVASCULAR CLOTTING. Ann Intern Med. 1964 Jul;61:116–123. doi: 10.7326/0003-4819-61-1-116. [DOI] [PubMed] [Google Scholar]
  3. BELL W. N., ALTON H. G. A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. Nature. 1954 Nov 6;174(4436):880–881. doi: 10.1038/174880a0. [DOI] [PubMed] [Google Scholar]
  4. Baggiolini M., Hirsch J. G., De Duve C. Resolution of granules from rabbit heterophil leukocytes into distinct populations by zonal sedimentation. J Cell Biol. 1969 Feb;40(2):529–541. doi: 10.1083/jcb.40.2.529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bainton D. F., Farquhar M. G. Differences in enzyme content of azurophil and specific granules of polymorphonuclear leukocytes. I. Histochemical staining of bone marrow smears. J Cell Biol. 1968 Nov;39(2):286–298. doi: 10.1083/jcb.39.2.286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Biggs R., Denson K. W., Riesenberg D., McIntyre C. The coagulant activity of platelets. Br J Haematol. 1968 Sep;15(3):283–296. doi: 10.1111/j.1365-2141.1968.tb01539.x. [DOI] [PubMed] [Google Scholar]
  7. COHN Z. A., HIRSCH J. G. The isolation and properties of the specific cytoplasmic granules of rabbit polymorphonuclear leucocytes. J Exp Med. 1960 Dec 1;112:983–1004. doi: 10.1084/jem.112.6.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cattan A., Schwarzenberg L., Amiel J. L., Schneider M., Shlumberger J. R., Mathé G. Syndrome de fibrinogénopénie au cours de leucémies aiguës. Rôle déterminant des cellules leucémiques. Etude "in vitro" de leur pouvoir fibrinolytique. Rev Fr Etud Clin Biol. 1966 Feb;11(2):155–168. [PubMed] [Google Scholar]
  9. EISEMAN G., STEFANINI M. Thromboplastic activity of leukemic white cells. Proc Soc Exp Biol Med. 1954 Aug-Sep;86(4):763–765. doi: 10.3181/00379727-86-21226. [DOI] [PubMed] [Google Scholar]
  10. GOOD R. A., THOMAS L. Studies on the generalized Shwartzman reaction. IV. Prevention of the local and generalized Shwartzman reactions with heparin. J Exp Med. 1953 Jun;97(6):871–888. doi: 10.1084/jem.97.6.871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. HIRSCH J. G. Phagocytin: a bactericidal substance from polymorphonuclear leucocytes. J Exp Med. 1956 May 1;103(5):589–611. doi: 10.1084/jem.103.5.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hirsh J., Buchanan J. G., De Gruchy G. C., Baikie A. G. Hypofibrinogenaemia without increased fibrinolysis in leukaemia. Lancet. 1967 Feb 25;1(7487):418–420. doi: 10.1016/s0140-6736(67)91178-6. [DOI] [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. MARTIN H., ROKA L. Beeinflussung der Blutgerinnung durch Leukocyten. Klin Wochenschr. 1951 Aug 1;29(29-30):510–512. doi: 10.1007/BF01483627. [DOI] [PubMed] [Google Scholar]
  15. McKay D. G., Margaretten W., Phillips L. L. The role of the leukocyte in the generalized Shwartzman reaction. Lab Invest. 1967 Apr;16(4):511–515. [PubMed] [Google Scholar]
  16. Michell R. H., Karnovsky M. J., Karnovsky M. L. The distributions of some granule-associated enzymes in guinea-pig polymorphonuclear leucocytes. Biochem J. 1970 Jan;116(2):207–216. doi: 10.1042/bj1160207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. NEMERSON Y., SPAET T. H. THE ACTIVATION OF FACTOR X BY EXTRACTS OF RABBIT BRAIN. Blood. 1964 May;23:657–668. [PubMed] [Google Scholar]
  18. Nemerson Y. The phospholipid requirement of tissue factor in blood coagulation. J Clin Invest. 1968 Jan;47(1):72–80. doi: 10.1172/JCI105716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nemerson Y. The reaction between bovine brain tissue factor and factors VII and X. Biochemistry. 1966 Feb;5(2):601–608. doi: 10.1021/bi00866a029. [DOI] [PubMed] [Google Scholar]
  20. Niemetz J., Nossel H. L. Activated coagulation factors: in-vivo and in-vitro studies. Br J Haematol. 1969 Apr;16(4):337–351. doi: 10.1111/j.1365-2141.1969.tb00411.x. [DOI] [PubMed] [Google Scholar]
  21. Ottolenghi A. C. Cationic antibiotics and phospholipase C as tools in the study of phospholipid structure and function. I. Inhibition of the in vitro clotting system by cationic antibiotics. Can J Biochem. 1967 Feb;45(2):239–244. doi: 10.1139/o67-026. [DOI] [PubMed] [Google Scholar]
  22. ROSENTHAL R. L. Acute promyelocytic leukemia associated with hypofibrinogenemia. Blood. 1963 Apr;21:495–508. [PubMed] [Google Scholar]
  23. SHAPIRO S. S., McKAY D. G. The prevention of the generalized Shwartzman reaction with sodium warfarin. J Exp Med. 1958 Mar 1;107(3):377–381. doi: 10.1084/jem.107.3.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. SOULIER J. P., LARRIEU M. J. étude analytique des temps de Quick allongés. Dosages de prothrombine, de proconvertine et de proaccélérine. Sang. 1952;23(7):549–559. [PubMed] [Google Scholar]
  25. Saba H. I., Roberts H. R., Herion J. C. The anticoagulant activity of lysosomal cationic proteins from polymorphonuclear leukocytes. J Clin Invest. 1967 Apr;46(4):580–589. doi: 10.1172/JCI105559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. THOMAS L., GOOD R. A. Studies on the generalized Shwartzman reaction: I. General observations concerning the phenomenon. J Exp Med. 1952 Dec;96(6):605–624. doi: 10.1084/jem.96.6.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. WEISSMANN G., THOMAS L. Studies on lysosomes. I. The effects of endotoxin, endotoxin tolerance, and cortisone on the release of acid hydrolases from a granular fraction of rabbit liver. J Exp Med. 1962 Oct 1;116:433–450. doi: 10.1084/jem.116.4.433. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES